• +852 2528 3061
  • +852 2865 6283
  • [email protected]
EN|中
  • About HKAPI
  • Code of Practice
  • Position Papers
  • What’s New
    • Upcoming Training
    • Events
    • Newsletters
  • Member’s Area
  • Resources
  • About HKAPI
  • Code of Practice
  • Position Papers
  • What’s New
    • Upcoming Training
    • Events
    • Newsletters
  • Member’s Area
  • Resources
09 Mar 26

Regulatory Intelligence Sharing

  • louisayuen
  • No Comments
HKAPI Regulatory Affairs Working Group (RAWG) hosted a "Regulatory Intelligence Sharing" session on 9 March 2026.
Read More
10 Jul 25

Regulatory Briefing Session on CMPR & “1+” Mechanism

  • louisayuen
  • No Comments
To help members understand the latest policy, the HKAPI Regulatory Affairs Working Group held a workshop on July 10, 2025, focusing on the CMPR's strategic plan and the "1+" mechanism.
Read More
22 Nov 24

Regulatory Briefing Session on Extending “1+” Mechanism

  • HKAPI
  • No Comments
The Drug Office, Department of Health, arranged a briefing seminar on extending the "1+" mechanism for HKAPI members on 22 Nov 2024.
Read More
30 Apr 24

Regulatory Briefing Session on “1+” Mechanism and Enhancement Measures

  • HKAPI
  • No Comments
The HKAPI Regulatory Working Group recently co-organized a briefing session with the Department of Pharmacology and Pharmacy of HKU, on the "1+" mechanism and its enhancement measures on April 2024.
Read More
05 Dec 23

Good Registration Practices and Best Practice Workshop (Day 2)

  • HKAPI
  • No Comments
Following the highly productive Day 1 workshop held on 24 Nov, the Regulatory Education Workshop Day 2 took place on 5 Dec, with over hundred participants from the pharmaceutical industry and pharmacy students.
Read More
24 Nov 23

Good Registration Practices and Best Practice Workshop (Day 1)

  • HKAPI
  • No Comments
To facilitate good submission practices of the industry, the HKAPI Regulatory Working Group recently organized a 2-day workshop. Day 1 of the workshop was held on 24 November 2023
Read More
13 Jul 23

Regulatory Intelligence Forum

  • HKAPI
  • No Comments
The HKAPI Regulatory Working Group recently held a forum for its members to exchange views on regulatory intelligence. Around 60 members attended the event.
Read More
13 Feb 23

Briefing session for Regulatory Intelligence Survey

  • vickyhkapi
  • No Comments
The Hong Kong Association of Pharmaceutical Industry organized a successful briefing session for its Regulatory Intelligence Survey, attracting over 50 members to join the event.
Read More
11 Nov 22

Asia Summit on Global Health 2022

  • vickyhkapi
  • No Comments
Asia Summit on Global Health 2022 It is a great privilege for The Hong Kong Association of the Pharmaceutical Industry to join the Asia Summit on Global Health 2022 organized […]
Read More

Pharmaceutical Promotion: UMAO & related laws and regulations

  • June 28, 2022
  • vickyhkapi
  • No Comments
To ensure members have a thorough understanding of the relevant laws, regulations and Codes regarding medicinal material communicating to the public via different mediums, the HKAPI organises an event with law enforcement authorities and experts to explain the law and its enforcement.
Read More
1 2 3

Recent Posts

  • CEO Meeting – Enlistment of Innovative Medicine in Hong Kong
  • Innovation for a Sustainable Healthcare System: HKAPI Celebrates Its 58th Anniversary Dinner
  • Strengthening Ethical Standards: HKAPI Holds Code of Practice Train-the-Trainer Workshop
  • HKAPI AGM and Formation of the New Board
  • Regulatory Intelligence Sharing

Categories

  • Advocacy27
  • Association News123
  • Business1
  • Code of Practice15
  • Industry News35
  • Market Access20
  • Patient Empowerment8
  • Primary Healthcare4
  • Public Education6
  • Recreational9
  • Regulatory Affairs22
  • Strategy47
  • Workshop & Training68

Archives

  • October 2026 1
  • June 2026 1
  • April 2026 1
  • March 2026 2
  • January 2026 1
  • December 2025 1
  • September 2025 1
  • August 2025 2
  • July 2025 1
  • June 2025 2
  • April 2025 2
  • March 2025 2
  • February 2025 2
  • January 2025 1
  • November 2024 2
  • October 2024 1
  • August 2024 4
  • June 2024 1
  • May 2024 1
  • April 2024 2
  • March 2024 1
  • January 2024 2
  • December 2023 3
  • November 2023 3
  • October 2023 4
  • July 2023 2
  • June 2023 1
  • May 2023 3
  • April 2023 1
  • March 2023 4
  • February 2023 2
  • January 2023 3
  • November 2022 2
  • October 2022 1
  • September 2022 1
  • August 2022 1
  • July 2022 2
  • June 2022 2
  • April 2022 3
  • March 2022 3
  • February 2022 1
  • January 2022 3
  • December 2021 2
  • November 2021 1
  • October 2021 2
  • September 2021 1
  • May 2021 2
  • April 2021 1
  • March 2021 1
  • January 2021 1
  • December 2020 1
  • November 2020 1
  • October 2020 2
  • September 2020 1
  • April 2020 1
  • February 2020 2
  • December 2019 4
  • November 2019 1
  • October 2019 2
  • September 2019 1
  • August 2019 2
  • June 2019 4
  • May 2019 3
  • April 2019 3
  • March 2019 2
  • February 2019 2
  • December 2018 2
  • November 2018 4
  • October 2018 1
  • May 2018 1
  • April 2018 1
  • March 2018 2
  • February 2018 1
  • January 2018 1
  • December 2017 2
  • November 2017 3
  • October 2017 1
  • September 2017 2
  • August 2017 1
  • May 2017 1
  • March 2017 3
  • January 2017 2
  • December 2016 2

© The Hong Kong Association of the Pharmaceutical Industry | 香港科研製藥聯會

All Right Reserved

Disclaimer

Privacy

Terms of Use